CircNUP98 Suppresses the Maturation of miR-519a-3p in Glioblastoma

Circular RNA (circNUP98) has been reported to promote renal cancer; however, its role in other cancers is unknown. The function of circNUP98 in glioblastoma (GB) cancer was explored in this study. A total of 58 GB tissue samples were collected to study the expression of circNUP98 and miR-519a-3p [both the mature and pre-mature microRNA (miRNA)] by quantitative real-time PCR (RT-qPCR) and heatmap analysis. The subcellular location that expresses circNUP98 was analyzed by nuclear fractionation assay. RNA pull-down assay was performed to evaluate the interaction between circNUP98 and pre-mature miR-519a-3p. Overexpression assays were performed to investigate the role of circNUP98 in the regulation of both the mature and pre-mature miR-519a-3p. The role of circNUP98 and miR-519a-3p in GB cell proliferation was explored by 5-bromo-2-deoxyuridine (BrdU) assay and was assessed in mouse xenograft model. Heatmap analysis showed that circNUP98 and pre-mature miR-519a-3p were upregulated in GB, while mature miR-519a-3p was downregulated in GB. Across the cancer tissues, circNUP98 was inversely correlated with mature miR-519a-3p, but positively correlated with pre-mature miR-519a-3p. In GB cells, circNUP98 was localized to both the nucleus and cytoplasm and it interacted with pre-mature miR-519a-3p. In GB cells, circNUP98 increased the expression levels of pre-mature miR-519a-3p and decreased the expression levels of mature miR-519a-3p. BrdU and cholecystokinin octapeptide (CCK-8) assays illustrated that overexpression of circNUP98 reduced the inhibitory effects of miR-519a-3p on cell proliferation. CircNUP98 contributed to larger tumors, which resulted in significantly reduced mice survival. CircNUP98 suppresses the maturation of miR-519a-3p to promote GB cell proliferation.

[1]  Tao Jiang,et al.  Circular RNA-encoded oncogenic E-cadherin variant promotes glioblastoma tumorigenicity through activation of EGFR–STAT3 signalling , 2021, Nature Cell Biology.

[2]  Jianguo Xu,et al.  Recent incidence trend of elderly patients with glioblastoma in the United States, 2000–2017 , 2021, BMC cancer.

[3]  Xianqun Fan,et al.  CircRNA-vgll3 promotes osteogenic differentiation of adipose-derived mesenchymal stem cells via modulating miRNA-dependent integrin α5 expression , 2020, Cell Death & Differentiation.

[4]  Jie Yao,et al.  A novel circRNA, circNUP98, a potential biomarker, acted as an oncogene via the miR‐567/ PRDX3 axis in renal cell carcinoma , 2020, Journal of cellular and molecular medicine.

[5]  Hui-Kuan Lin,et al.  Downregulation of miR-519a Predicts Poor Prognosis and Contributes to Tumor Progression in Gastric Cancer , 2019, Oncology Research and Treatment.

[6]  F. Wang,et al.  circRNA CDR1as Regulated the Proliferation of Human Periodontal Ligament Stem Cells under a Lipopolysaccharide-Induced Inflammatory Condition , 2019, Mediators of inflammation.

[7]  J. Parvizi,et al.  Age Alone is Not a Risk Factor for Periprosthetic Joint Infection. , 2019, The Journal of hospital infection.

[8]  Brandon A. Sherrod,et al.  Effect of patient age on glioblastoma perioperative treatment costs: a value driven outcome database analysis , 2019, Journal of Neuro-Oncology.

[9]  Kyle R. Noll,et al.  Depressive symptoms and executive function in relation to survival in patients with glioblastoma , 2019, Journal of Neuro-Oncology.

[10]  S. Ge,et al.  The novel roles of circRNAs in human cancer , 2019, Molecular Cancer.

[11]  Chern Ein Oon,et al.  Molecular targeted therapy: Treating cancer with specificity , 2018, European journal of pharmacology.

[12]  Tomasz Tykocki,et al.  Ten-year survival in glioblastoma. A systematic review , 2018, Journal of Clinical Neuroscience.

[13]  Z. Zeng,et al.  Circular RNAs (circRNAs) in cancer. , 2018, Cancer letters.

[14]  A. Huang,et al.  miR-519a enhances chemosensitivity and promotes autophagy in glioblastoma by targeting STAT3/Bcl2 signaling pathway , 2018, Journal of Hematology & Oncology.

[15]  A. Qutub,et al.  Advances in Glioblastoma Multiforme Treatment: New Models for Nanoparticle Therapy , 2018, Front. Physiol..

[16]  Liu Ming,et al.  A novel protein encoded by the circular form of the SHPRH gene suppresses glioma tumorigenesis , 2018, Oncogene.

[17]  Jacob S. Young,et al.  Management of glioblastoma in elderly patients , 2017, Journal of the Neurological Sciences.

[18]  Manfred Westphal,et al.  EGFR as a Target for Glioblastoma Treatment: An Unfulfilled Promise , 2017, CNS Drugs.

[19]  M. Schaffer,et al.  Glioblastoma Multiforme, Diagnosis and Treatment; Recent Literature Review. , 2017, Current medicinal chemistry.

[20]  K. Ligon,et al.  Glioblastoma targeted therapy: updated approaches from recent biological insights , 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

[21]  A. Huang,et al.  MiR-519a functions as a tumor suppressor in glioma by targeting the oncogenic STAT3 pathway , 2016, Journal of Neuro-Oncology.

[22]  Wei Yang,et al.  MicroRNA-519a promotes tumor growth by targeting PTEN/PI3K/AKT signaling in hepatocellular carcinoma , 2015, International journal of oncology.

[23]  Alfredo Hidalgo-Miranda,et al.  miRNA biogenesis: Biological impact in the development of cancer , 2014, Cancer biology & therapy.

[24]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[25]  J. Weissmann An Unfulfilled Promise , 1954, Tempo.

[26]  T. Cloughesy,et al.  Adult Glioblastoma. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.